ABSTRACT
Objective To explore the therapeutic mechanism of Huangqin Zhengqi Capsule(HZC)for the syndrome of damp retention in middle-jiao.Methods The rat model of damp retention in middle-jiao was established according to the literature.HZC was administered by gastric gavage in the dosage of 0.175,0.350 and 0.700 g/kg.After treatment,the serum gastrin content,small intestinal absorbency to D-xylose,small intestinal peristalsis,activities of gastric mucosal protective factors such as superoxide dismutase (SOD) and catalase(CAT)as well as gastric pathologic changes were observed.Results HZC can obviously increase serum gastrin content,increase small intestinal absorbency to D-xylose and peristalsis of small intestine,increase the activities of SOD and CAT,as well as improve the gastric pathologic changes in model rats(P
ABSTRACT
Objective To establish a quality standard for Huangqin Zhengqi Capsules (HZC). Methods HZC was identified by TLC and HPLC and the effective components of HZC were determined by HPLC. Results The relevant spots in Cortex Magnoliae Officinalis and Herba Pogostemonis were identified by TLC, and the characteristic compounds of Rhizoma Atractylodis were identified by HPLC; the contents of hesperidin, baicalin, honokiol and magnolol could be determined by HPLC. Conclusion The quality standard is simple, feasible and repeatable, and can be used for quality supervisory and control in Huangqin Zhengqi Capsule.